Clinical Trial Update: A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating inhaled TQC3927 in healthy adults has been completed; COPD is listed among the trial conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TQC3927

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED